Free Trial
NYSE:CCM

Concord Medical Services Q4 2025 Earnings Results & Report

Concord Medical Services logo
$3.71 0.00 (-0.11%)
Closing price 10/16/2026 03:58 PM Eastern
Extended Trading
$3.64 -0.07 (-1.78%)
As of 10/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Concord Medical Services reported Q4 2025 earnings on April 29, 2026. The company reported EPS of -$1.08.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens

Concord Medical Services EPS Results

Actual EPS
-$1.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
5 of last 8 quarters

Concord Medical Services Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Concord Medical Services Q4 2025 Earnings FAQ

Concord Medical Services (NYSE:CCM) reported earnings of -$1.08 per share for Q4 2025. The report was announced on Wednesday, April 29, 2026.

Concord Medical Services Earnings Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
CCM Share News Today
Concord Medical Services Holdings Ltd
See More Concord Medical Services Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Concord Medical Services? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Concord Medical Services and other key companies, straight to your email.

About Concord Medical Services

Concord Medical Services (NYSE:CCM) is a China-based healthcare services company focused on oncology care and medical imaging. The company has operated cancer treatment centers and imaging centers that provide services such as radiation therapy, diagnostic imaging and related oncology support.

Concord Medical has historically developed and managed facilities in cooperation with hospitals and other medical institutions, helping provide access to advanced cancer-treatment and diagnostic equipment. Its operations have primarily served patients in mainland China through a network of treatment and imaging facilities.

Founded in 2004 and headquartered in Beijing, Concord Medical was formerly listed on the New York Stock Exchange under the symbol CCM. The company completed a transaction to become privately held in 2021, after which its NYSE-listed shares were no longer publicly traded.

View Concord Medical Services Profile